Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fortress Biotech

2.00
+0.12006.38%
Post-market: 2.00-0.0005-0.02%19:36 EDT
Volume:327.68K
Turnover:634.92K
Market Cap:59.14M
PE:-0.91
High:2.00
Open:1.90
Low:1.89
Close:1.88
Loading ...
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2024

Major Issues Report

Form 8-K - Current report
Jul 25, 2024

Major Issues Report

Form 8-K - Current report
Jul 19, 2024

Major Issues Report

Form 8-K - Current report
Jul 05, 2024

Major Issues Report

Form 8-K - Current report
Jun 28, 2024

Major Issues Report

Form 8-K - Current report
Jun 28, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 25, 2024

Correspondence

Form CORRESP - Correspondence
Jun 25, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 31, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 29, 2024

Correspondence

Form CORRESP - Correspondence
May 29, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 17, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 28, 2024

Major Issues Report

Form 8-K - Current report